Patala (Stereospermum suaveolens)

Patala (Stereospermum suaveolens) contains bioactive compounds including steroids, flavonoids, and saponins that demonstrate hepatoprotective and gastroprotective properties through antioxidant mechanisms. This Ayurvedic herb shows promise for supporting digestive and liver health, though clinical evidence remains limited to animal studies.

Origin & History

Patala (Stereospermum suaveolens) is a deciduous tree native to India belonging to the Bignoniaceae family, traditionally used in Ayurvedic medicine. The medicinal parts include roots, root bark, flowers, fruits, leaves, and seeds, typically prepared as decoctions, powders, or pastes. The plant contains quinones, phenolics, and bitter substances including lapachol, scutellarein, and various fatty acids.

Historical & Cultural Context

Patala has been used for centuries in Ayurveda as part of Dashamoola (group of 10 roots) for Vata-related disorders including pain, inflammation, edema, asthma, and arthritis. Traditional applications include treating digestive problems, blood disorders, cardiac health, respiratory conditions, and as a diuretic and fever reducer. In Ayurvedic theory, roots balance Vata dosha while flowers and fruit balance Kapha-Pitta.

Health Benefits

• May support digestive health and protect against ulcers (preclinical animal studies only)
• Potentially supports liver function through antioxidant activity (preclinical evidence only)
• May help modulate immune system response (in vivo animal studies, no human data)
• Traditional use for respiratory conditions like asthma and bronchitis (no clinical validation)
• May provide neuroprotective effects (preclinical studies only, no human trials)

How It Works

Patala exerts its effects primarily through antioxidant compounds including steroids, flavonoids, and saponins that scavenge free radicals and reduce oxidative stress. The hepatoprotective activity involves modulation of liver enzymes and protection of hepatocyte membranes from damage. Gastroprotective effects occur through enhancement of gastric mucus production and reduction of inflammatory mediators in the digestive tract.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on Stereospermum suaveolens. All available evidence comes from preclinical animal studies investigating antiulcer, gastroprotective, neuroprotective, hepatoprotective, and immunomodulatory effects. Human clinical validation is completely absent.

Clinical Summary

Current evidence for Patala comes exclusively from preclinical animal studies, with no published human clinical trials available. Animal studies have shown significant hepatoprotective effects against chemically-induced liver damage and gastroprotective activity against ulcer formation. The immune modulatory effects have been demonstrated in vivo but require further investigation to establish therapeutic relevance. Clinical research in humans is needed to validate traditional uses and establish safe, effective dosing protocols.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 2-3% by weight", "fiber": "Approximately 4-5% by weight"}, "micronutrients": {"vitamin_C": "Trace amounts, specific concentration not well-documented", "calcium": "Approximately 20-30 mg per 100g", "iron": "Approximately 0.5-1 mg per 100g"}, "bioactive_compounds": {"stereospermin": "Specific concentration not well-documented, known for potential antioxidant properties", "flavonoids": "Present, specific types and concentrations not well-documented", "tannins": "Present, specific concentration not well-documented"}, "bioavailability_notes": "Limited data on bioavailability; traditional preparation methods may influence nutrient absorption. Further research needed to determine exact bioavailability of compounds."}

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials have been conducted. Traditional Ayurvedic practice suggests root/root bark decoctions, with general herb dosages of 3-6g/day of powder, though this is not validated for Patala specifically. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ashwagandha, Guduchi, Tulsi, Triphala, Turmeric

Safety & Interactions

Safety data for Patala is limited due to lack of human clinical studies, making it difficult to establish comprehensive safety profiles. No specific drug interactions have been documented, though caution is advised when combining with hepatic medications due to its liver-affecting properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with existing liver conditions should consult healthcare providers before use given the herb's hepatic activity.